Author: Islam, Anwarul
Title: Higherâ€risk myelodysplastic syndrome in an elderly patient: Longâ€term partial remission with lowâ€dose prednisone, Gâ€CSF, and epoetin alfa Cord-id: e8f3twfq Document date: 2021_9_7
ID: e8f3twfq
Snippet: Currently, most patients with higherâ€risk MDS are treated with 5â€azacitidine or decitabine. These agents are toxic. The treatment described here is safe, devoid of toxicity, fosters improved quality of life, and helps reduce transfusion requirements.
Document: Currently, most patients with higherâ€risk MDS are treated with 5â€azacitidine or decitabine. These agents are toxic. The treatment described here is safe, devoid of toxicity, fosters improved quality of life, and helps reduce transfusion requirements.
Search related documents:
Co phrase search for related documents- acute distress and long term survival: 1, 2, 3
- acute distress and low hemoglobin: 1, 2, 3
- acute distress and low hemoglobin level: 1
- acute distress and low intensity: 1, 2, 3
- acute distress and low remain: 1
- long term remission and low remain: 1
Co phrase search for related documents, hyperlinks ordered by date